Clinicopathological features | Number | DC-SINGR expressiona | P-valueb | |
---|---|---|---|---|
Gender | ||||
 Male | 159 | 68.57 ± 3.490 | 0.422 | |
 Female | 48 | 74.31 ± 5.895 | ||
Age | ||||
 <65 | 126 | 67.41 ± 3.594 | 0.302 | |
 ≥65 | 81 | 73.78 ± 5.273 | ||
Stage | ||||
 T1 | 15 | 51.59 ± 6.554 | 0.038 | |
 T2 | 23 | 52.95 ± 5.010 | ||
 T3 | 36 | 76.65 ± 8.575 | ||
 T4 | 102 | 69.95 ± 4.122 | ||
 Tx | 31 | 83.33 ± 9.121 | ||
Invasive-lyph node | ||||
 N0 | 47 | 60.18 ± 4.934 | 0.024 | |
 N1 | 40 | 62.25 ± 5.088 | ||
 N2 | 43 | 65.34 ± 5.896 | ||
 N3 | 41 | 78.84 ± 7.813 | ||
 Nx | 36 | 86.37 ± 9.302 | ||
Invasive-metastasis | ||||
 M0 | 151 | 65.82 ± 3.283 | 0.025 | |
 M1 | 56 | 80.92 ± 6.551 | ||
 CEA |  |  |  | |
≤5 | 130 | no check 23 | 64.18 ± 3.259 | 0.0008 |
>5 | 54 | 87.34 ± 7.092 | ||
CA199 | Â | Â | Â | |
≤35 | 140 | no check 29 | 69.76 ± 3.668 | 0.225 |
>35 | 36 | 79.55 ± 6.977 |